Antithrombin activity of lepirudin adsorbed to silicone (polydimethylsiloxane) tubingHORNE, Mcdonald K; BROKAW, Kimberly J.Thrombosis research. 2003, Vol 112, Num 1-2, pp 111-115, issn 0049-3848, 5 p.Article

Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteersKAUTZLEBEN, Michael; STEIN, Günter; SPERSCHNEIDER, Heide et al.Thrombosis research. 2004, Vol 113, Num 3-4, pp 187-195, issn 0049-3848, 9 p.Article

Refludan : étude de pharmacosurveillance = Refludan: pharmacosurveillance studyWINICKI, J.La Presse médicale (1983). 1998, Vol 27, pp 31-32, issn 0755-4982, SUP2Conference Paper

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammationHOMONCIK, Monika; PERNERSTORFER, Thomas; REITER, Rosemarie et al.Thrombosis research. 2002, Vol 108, Num 1, pp 91-95, issn 0049-3848, 5 p.Article

Lepirudin use in a neonate with heparin-induced thrombocytopeniaNGUYEN, Thuy N; GAL, Peter; RANSOM, J. Laurence et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 229-233, issn 1060-0280, 5 p.Article

Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudinEICHLER, Petra; LUBENOW, Norbert; STROBEL, Ulrike et al.Blood. 2004, Vol 103, Num 2, pp 613-616, issn 0006-4971, 4 p.Article

Overview of Direct Thrombin Inhibitors in Clinical PracticeBOUNAMEAUX, Henri.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 12-17, issn 0094-6176, 6 p., SUP1Article

Impact of smart infusion technology on administration of anticoagulants (Unfractionated heparin, Argatroban, Lepirudin, and Bivalirudin)FANIKOS, John; FIUMARA, Karen; BAROLETTI, Steve et al.The American journal of cardiology. 2007, Vol 99, Num 7, pp 1002-1005, issn 0002-9149, 4 p.Article

Refludan: Le premier traitement de la thrombopénie induite par l'héparine (TIH) de type II = Treatment of heparin-induced thrombocytopenia type IICAMEZ, A.La Presse médicale (1983). 1998, Vol 27, pp 28-30, issn 0755-4982, SUP2Conference Paper

The Anti-Inflammatory Effects of Argatroban Can Be Differentiated from Other Direct Thrombin Inhibitors : Experimental and Clinical ObservationsHOPPENSTEADT, Debra A; JESKE, Walter; WALENGA, Jeanine M et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 97-102, issn 0094-6176, 6 p., SUP1Article

Treatment options for heparin-induced thrombocytopeniaGREINACHER, Andreas.American journal of health-system pharmacy. 2003, Vol 60, pp S12-S18, issn 1079-2082, SUP5Article

Lepirudin prevents lethal effects of Shiga toxin in a canine modelRAIFE, Thomas; FRIEDMAN, Kenneth D; FENWICK, Brad et al.Thrombosis and haemostasis. 2004, Vol 92, Num 2, pp 387-393, issn 0340-6245, 7 p.Article

Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopeniaCALL, Jason T; DELIARGYRIS, Efthymios N; SANE, David C et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 3, pp 297-304, issn 0094-6176, 8 p.Article

Traitement par lépirudine au cours d'une thrombopénie à l'héparine : À propos d'un cas = Treatment with lepirudin in heparin induced thrombocytopeniaNIPPERT, M; DE MAISTRE, E; RODERMANN, M et al.Archives des maladies du coeur et des vaisseaux. 2002, Vol 95, Num 12, pp 1234-1238, issn 0003-9683, 5 p.Article

The thrombin inhibitors hirudin and Refludan® activate the soluble guanylyl cyclase and the cGMP pathway in washed human plateletsKOBSAR, Anna; KOESSLER, Juergen; KEHRER, Linda et al.Thrombosis and haemostasis. 2012, Vol 107, Num 3, pp 521-529, issn 0340-6245, 9 p.Article

Severe anaphylactic reaction after repeated intermittent exposure to lepirudinVEACH, Sidney A; FRANKS, Amy M; ALLAN, Michael C et al.Pharmacotherapy. 2007, Vol 27, Num 5, pp 760-765, issn 0277-0008, 6 p.Article

The in vitro anticoagulant effects of Danaparoid, Fondaparinux, and Lepirudin in children compared to adultsIGNJATOVIC, Vera; SUMMERHAYES, Robyn; YAN YAN YIP et al.Thrombosis research. 2008, Vol 122, Num 5, pp 709-714, issn 0049-3848, 6 p.Article

Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapyGAJRA, Ajeet; VAJPAYEE, Neerja; SMITH, Arienne et al.American journal of hematology. 2007, Vol 82, Num 5, pp 391-393, issn 0361-8609, 3 p.Article

Effect of lepirudin on the international normalized ratioSTEPHENS, Jennifer L; KOERBER, John M; MATTSON, Joan C et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 28-31, issn 1060-0280, 4 p.Article

Overview of heparin-induced thrombocytopeniaSPINLER, Sarah A; DAGER, William.American journal of health-system pharmacy. 2003, Vol 60, pp S5-S11, issn 1079-2082, SUP5Article

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literatureKLENNER, Anne F; LUBENOW, Norbert; RASCHKE, Ricarda et al.Thrombosis and haemostasis. 2004, Vol 91, Num 4, pp 719-724, issn 0340-6245, 6 p.Article

Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomesRISCH, Lorenz; FISCHER, Joachim E; HERKLOTZ, Roberto et al.Intensive care medicine (Print). 2004, Vol 30, Num 8, pp 1615-1624, issn 0342-4642, 10 p.Article

In vitro effect of melagatran and lepirudin on clot-bound thrombinLEBRAZI, Jamal; ELALAMY, Ismail; SAMAMA, Meyer Michel et al.Thrombosis research. 2003, Vol 110, Num 4, pp 249-252, issn 0049-3848, 4 p.Article

Circulation extracorporelle sous lépirudine (Refludan®) dans un contexte de thrombopénie induite par l'héparine = Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopeniaBOINOT, C; LANQUETOT, H; MACCHI, L et al.Annales françaises d'anesthésie et de réanimation. 2003, Vol 22, Num 7, pp 635-638, issn 0750-7658, 4 p.Article

Recommended and actual lepirudin doses in patients with renal insufficiencySAXER, Sarah B; SMITH, Brian S; GANDHI, Pritesh J et al.American journal of health-system pharmacy. 2003, Vol 60, Num 24, pp 2588-2593, issn 1079-2082, 6 p.Article